Nucleic acid therapeutics in cancer /
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana Press,
[2004]
|
| Series: | Cancer drug discovery and development.
|
| Subjects: |
Table of Contents:
- Antisense methodology / Fritz Eckstein
- Nucleic acid therapeutics / Alan M. Gewirtz
- Targeted genome modification via triple helix formation / Faye A. Rogers and Peter M. Glazer
- Therapeutic applications of ribozymes / John J. Rossi
- Use of catalytic DNA in target validation and therapeutics / Lun-Quan Sun
- Targeted destruction of small, stable RNAs / David A. Dunbar and Susan J. Baserga
- Mechanism of action of antisense RNA in eukaryotic cells / Zuo Zhang and Gordon G. Carmichael
- The transport of oligonucleotides into cells / R.L. Juliano
- Peptide-mediated delivery of antisense oligonucleotides and related material / Eric VivÄs, Jean Philippe Richard and Bernard Lebleu
- Molecular vectors for gene delivery to cancer cells / Guy Zuber ... [et al.]
- Considerations on the design of antisense oligonucleotides / Rosel Kretschmer-Kazemi Far, Jens Warnecke and Georg Sczakiel
- Identification of hybridization accessible sequence in messenger RNA / Lida K. Gifford, Ponzy Lu, and Alan M. Gewirtz
- Nucleic acids as gene targeting therapeutics / Joanna B. Opalinska and Susan E. Shetzline
- LY900003 (Isis 3521) and G3139 (Genasense; Oblimersen) / C.A. Stein ... [et al.]
- Antisense protein kinase A-RI restores normal signal transduction signatures to inhibit tumor growth / Yoon S. Cho-Chung.